Evidence map›Paper›PMID 40807042›Full record

ArticleJournal of clinical medicine2025

Comparative Analysis of the Long-Term Real-World Efficacy of Interleukin-17 Inhibitors in a Cohort of Patients with Moderate-to-Severe Psoriasis Treated in Poland.

Wiktor Kruczek, Aleksandra Frątczak, Iga Litwińska-Inglot, Karina Polak, Zuzanna Pawlus, Paulina Rutecka, Beata Bergler-Czop, Bartosz Miziołek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wiktor KruczekStudents' Scientific Association at the Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20/24 Francuska St., 40-067 Katowice, Poland.ORCID 0009-0008-5193-2074
Aleksandra FrątczakDepartment of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20/24 Francuska St., 40-067 Katowice, Poland.
Iga Litwińska-InglotStudents' Scientific Association at the Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20/24 Francuska St., 40-067 Katowice, Poland.
Karina PolakDepartment of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20/24 Francuska St., 40-067 Katowice, Poland.ORCID 0000-0001-7785-5427
Zuzanna PawlusStudents' Scientific Association at the Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20/24 Francuska St., 40-067 Katowice, Poland.ORCID 0000-0001-5228-4234
Paulina RuteckaStudents' Scientific Association at the Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20/24 Francuska St., 40-067 Katowice, Poland.ORCID 0009-0000-7822-4651
Beata Bergler-CzopDepartment of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20/24 Francuska St., 40-067 Katowice, Poland.
Bartosz MiziołekDepartment of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20/24 Francuska St., 40-067 Katowice, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bimekizumabinterleukin-17Interleukin Inhibitorsixekizumabpsoriasissecukinumab

Identifiers

PMID40807042
PMCPMC12347414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.